News About: Pharm. Industry
Second hot round of impotence drug markets.
Celebrating the 5th year and 1st year anniversaries for Viagra and the followers like Levitra and Cialis, they are now getting into the second round of the market competition that seemed to be far sharp struggles than...
New natural drugs seen jumping in sales
Sales of new natural drugs in Korea are expected to pick up in the years to come, back both by therapeutic efficacy and aggressive marketing campaigns, even in the face of local doctors' persisted disbelief over Korea...
Zyprexa, atypical antipsychotic medication with proven safety and efficacy
The Korean College of Neuropsychopharmacology said it held on September 3 its autumn symposium for Zyprexa (olanzapine), a psychotropic medication indicated for the treatment of acute manic episodes associated with bi...
Reshuffle of drug maker's website on the rise.
The pharmaceutical are reshuffling their website in a bid to refresh company images and to make more efficient publicity. 23 drug manufacturers already set up their own website, of which 10 companies already modified...
Iressa and Velcade co-shared 2004 Pharmaceutical Achievement Awards
AstraZeneca's Iressa (gefitinib) and Millennium Pharmaceuticals's Velcade (bortezomib) co-shared the Oncology Compound of the Year at the third annual Pharmaceutical Achievement Award held in Boston. The Pharmaceutica...
Domestic firms need to develop combined preparations as new chemical form
Pharmaceutical business sources cautioned that Korean companies have to focus on the development of new chemical drugs containing at least two ingredients, as a number of multinational firms are pushing ahead with the...
Cialis new marketing concept on weekend wellbeing.
Celebrating one year anniversary of Cialis market launching Lilly Korea announced on Sept. 6 that the marketing promotional point on Cialis had changed from "24 hours long lasting effect" to "Weekend Freedom".
Than...
GSK acquires anti-thrombotic agents from Sanofi-Aventis
GSK announced on September 7 the successful acquisition, on a worldwide basis, of the injectable anti-thrombotic agents Fraxiparine, Fraxodi and Arixtra and related assets including a manufacturing facility located in...
Kim Young-jin appointed new CEO in Korea's Sanofi-Aventis
Kim Young-jin, Vice chairman of Handok-Aventis Pharma, is appointed a new chief executive officer of Sanofi-Aventis in Korea, and a new Chief Operating Officer Steve Oldfield, regional manager of Sanofi-Synthelabo in ...
Big foreign makers face heat from generics
Some of foreign-invested pharmaceutical firms, such as Pfizer Korea and Handok Pharm, face an aggressive assault as local firms look to steal market share by launching a number of amlodipine and glimepiride generics t...
